MDR1 Breed Prevalence: Which Dogs Carry the Mutation?
One of the first questions I hear from new clients is some version of "My dog is a [breed], do I need to worry about MDR1?" The answer depends entirely on the breed, the population studied, and increasingly on whether the dog has any herding breed ancestry at all. After sixteen years of working with MDR1 testing data, I can tell you that the mutation's reach is wider than most people assume and the variation between breeds is more dramatic than any simple list conveys.
What follows is the most comprehensive breed-by-breed prevalence breakdown I can compile from published research, laboratory databases, and my own clinical experience. I will be blunt about the numbers, honest about where data is limited, and clear about what the prevalence rates actually mean for individual dog owners.
Understanding Prevalence Numbers
Before we look at specific breeds, you need to understand what prevalence numbers represent and what they do not. When I say that approximately 70% of Collies carry at least one copy of the MDR1 mutation, I mean that in a randomly sampled population of Collies, roughly seven out of ten will test as either N/M (carrier) or M/M (affected). The remaining three out of ten will be N/N (clear).
These numbers come from large-scale testing databases, primarily from Washington State University's Veterinary Clinical Pharmacology Laboratory and commercial testing companies like Embark, Wisdom Panel, and Orivet. Sample sizes vary enormously between breeds, which affects how confident we can be in the numbers. For Collies and Australian Shepherds, we have tens of thousands of test results. For some rarer breeds, we may have only a few hundred.
Prevalence vs. Individual Risk
A prevalence rate tells you the probability that a randomly selected dog from a breed carries the mutation. It does NOT tell you whether your specific dog has it. The only way to know your dog's individual status is to test. A Collie from a line that has been tested and bred clear for three generations may be N/N despite the breed's high overall prevalence.
High Prevalence Breeds (Over 25%)
These breeds have mutation frequencies high enough that testing is not optional. It is mandatory for responsible ownership. If you own any of these breeds and have not tested, stop reading and order a test today.
Collie (Rough and Smooth) — 65-75% Affected or Carrier
The Collie is ground zero for MDR1. The mutation was first identified in this breed by Dr. Katrina Mealey's team at Washington State University in 2001, and Collies remain the most heavily affected breed in the world. Washington State University estimates that about 70% of Collies carry at least one copy. In Dr. Mealey's 2002 study of 40 Collies from Washington and Idaho, 35% were homozygous affected (M/M), meaning they produce no functional P-glycoprotein whatsoever, 42% were carriers (N/M), and only 22% were genetically clear.
These numbers have been remarkably consistent across different populations: WSU reports about the same frequency in France and Australia as in the United States, and a Japanese study found a mutant allele frequency of 58.3% in Collies, suggesting the mutation predates the breed's geographic diversification. The founding population that established the modern Collie breed carried the mutation at high frequency, and it has been maintained through the breed's relatively closed gene pool ever since.
Australian Shepherd — 45-50% Affected or Carrier
Australian Shepherds are among the most affected breeds, at about 50% on WSU's breed list, a frequency that surprises many owners. Most of these dogs are carriers rather than M/M: in a study of 145 Australian Shepherds in Israel, whose allele frequency matched US, European and Japanese data, 9% were M/M. The high prevalence reflects shared ancestry with the Collie; despite the name, Australian Shepherds have significant historical crossbreeding with Collie-type dogs.
The Miniature American Shepherd, which was developed from small Australian Shepherds, carries a similar prevalence. Do not assume that size variants have different mutation frequencies. They share the same gene pool origins.
Shetland Sheepdog — About 15% in the US, Higher in Europe
Shelties often catch owners off guard because people associate MDR1 primarily with Collies and Aussies. WSU's breed list puts about 15% of Shetland Sheepdogs as affected or carriers, most of them carriers, but the figure depends heavily on the population: published mutant allele frequencies reach about 30% in continental Europe and 36% in the UK, against about 7% in the United States and 1% in Japan. The Sheltie's Collie ancestry explains the presence of the mutation, even where its frequency is lower than in full-size Collies.
Longhaired Whippet — 40-65% Affected or Carrier
This is the breed that confuses everyone because Whippets are sighthounds, not herding dogs. The Longhaired Whippet carries MDR1 at surprisingly high frequencies (about 50% on WSU's list), and genetic work has shown that its copy of the mutation is identical by descent with the Collie lineage, which points to herding-dog ancestry in the breed's development (Neff and colleagues, PNAS, 2004). Smooth-coated Whippets are not among the affected breeds, making the Longhaired Whippet an excellent case study in how herding-dog ancestry can carry a mutation into an otherwise unaffected breed.
McNab — About 30%
The McNab, a working ranch dog from Northern California, carries MDR1 at about 30% on WSU's breed list, consistent with its herding breed heritage. Testing data for McNabs is more limited than for AKC-recognized breeds.
Silken Windhound — About 30%
The second sighthound on the list. WSU puts the Silken Windhound at about 30%, and, as with the Longhaired Whippet, the mutation it carries traces back to the Collie lineage rather than appearing independently.
Moderate Prevalence Breeds (5-25%)
These breeds carry the mutation at lower frequencies. Testing is still strongly recommended, especially before any procedure requiring sedation or for dogs that may need the medications on our drug avoidance list.
Old English Sheepdog — 5-10%
Old English Sheepdogs show lower MDR1 prevalence than many expect given their appearance and herding classification. Most affected individuals are carriers rather than homozygous M/M, which means clinical drug reactions are less commonly reported in this breed. However, carriers can still show increased sensitivity to some P-glycoprotein substrates at higher doses.
German Shepherd — 5-10%
The German Shepherd's MDR1 frequency is lower than the Collie group but high enough to warrant testing. What makes the German Shepherd situation distinctive is the breed's popularity. With hundreds of thousands of German Shepherds worldwide, even a 5-10% prevalence rate translates to a massive absolute number of affected and carrier dogs. In clinical practice, I see more German Shepherd MDR1 questions than any breed except Collies and Aussies simply because there are so many of them.
White Swiss Shepherd — Moderate, Above the German Shepherd
The White Swiss Shepherd descends from the white lines of the German Shepherd, yet it carries the mutation more often: European and Israeli studies report mutant allele frequencies of about 15-17%, against a few percent in German Shepherds. In German Shepherds, the mutation has been found mainly in white dogs or dogs with a white parent or grandparent.
English Shepherd — 10-15%
Another working herding breed with moderate prevalence. English Shepherds are less commonly tested than Australian Shepherds or Collies, but the data we have suggests regular MDR1 occurrence consistent with shared ancestral genetics among British herding breeds.
Border Collie — 1-5%
This one surprises people in both directions. Some expect Border Collies to have high MDR1 prevalence because they are herding dogs. Others assume they are completely clear. The truth is that Border Collies carry MDR1 at low but non-zero rates. Approximately 1-2% are carriers, with homozygous affected individuals being very rare. The Border Collie's distinct genetic lineage from Collie-type dogs explains the lower prevalence.
Low Prevalence Does Not Mean No Risk
A 2% carrier rate in Border Collies still means thousands of affected dogs worldwide given the breed's popularity. If your Border Collie has not been tested, you are making an assumption. Test, do not guess.
Low Prevalence Breeds (Under 5%)
Outside the breeds above, MDR1 turns up at low or sporadic frequencies, with one exception worth flagging: crosses that include a herding breed. For these dogs, testing is advisable even if the individual probability of finding an affected dog is lower.
Mixed Breeds and Isolated Cases
- Mixed breeds: About 5% on WSU's list for mixed breeds in general, and about 10% for herding breed crosses. Any dog with herding breed heritage should be tested.
- Isolated reports: Single carriers have been reported in a Labradoodle and a Cocker Spaniel, breeds with no known link to the Collie lineage, and other laboratories report the mutation in the Black Mouth Cur, the Carolina Dog and the Chinook.
- Australian Cattle Dog: Not among the breeds in which the mutation has been documented (Neff and colleagues, 2004; WSU's breed list). A positive result in a Cattle Dog cross points to another ancestor.
The Mixed Breed Question
Mixed breed dogs are NOT automatically safe from MDR1. This is a misconception I encounter constantly, and it can be lethal. If your mixed breed has any herding breed ancestry — and with the popularity of Australian Shepherds and Border Collies in "designer" crosses, this is increasingly common — it may carry one or two copies of the mutation.
The rise of "Aussiedoodle," "Borderdoodle," and "Shollies" (Collie-Shepherd crosses) means that MDR1 is now present in dogs that do not look like herding breeds at all. A curly-coated Aussiedoodle with no visible herding breed characteristics can absolutely be M/M for MDR1.
Two crosses deserve a direct mention because owners search for them by name. The Australian Labradoodle is the opposite case: its documented foundation breeds are the Labrador Retriever, the Poodle, and the Cocker Spaniel, Irish Water Spaniel, and Curly Coat Retriever lines added later for coat consistency, none of which is a recognized MDR1 breed (the literature reports only isolated carriers, one Labradoodle and one Cocker Spaniel), so a Labradoodle bred strictly from that documented ancestry is not expected to carry elevated MDR1 risk. The catch is that "Labradoodle" is not a closed, regulated breed name, and a dog sold under it can carry additional, undisclosed ancestry, including a herding breed, that no pedigree will reveal. That gap, not the documented foundation breeds, is the real reason to test rather than assume. Likewise, a "Blue Heeler mix," meaning any cross involving an Australian Cattle Dog, gets no documented MDR1 risk from the Cattle Dog side, since the mutation has not been found in that breed; its risk comes from whatever the other parent contributes. A Golden Retriever x Australian Shepherd cross is a more direct case: a first-generation puppy can only inherit a mutant copy from the Australian Shepherd parent, and an untested Australian Shepherd carries at least one copy about half the time. A carrier parent passes the mutation to half its puppies and an M/M parent to all of them, so such puppies are usually carriers rather than M/M, but crossing them back to a herding line can produce M/M dogs.
DNA panels that combine breed ancestry with health screening, such as Wisdom Panel Essential or Embark's breed-and-health test, include MDR1 screening. If you have tested your mixed breed's ancestry and found any herding breed contribution above about 12.5% (one great-grandparent), request specific MDR1 testing. For guidance on testing options and costs, review our comprehensive testing guide.
Geographic Variation
MDR1 prevalence can vary between populations of the same breed in different countries. This variation reflects founder effects — if the dogs imported to establish a breed population in a new country happened to carry the mutation at different rates than the global average, that population will maintain different frequencies.
For example, published mutant allele frequencies for Australian Shepherds sit around 25-33% in the United States, Europe and Japan, but around 45% in the UK and Australia. Shetland Sheepdogs show an even wider spread, from about 1% in Japan and 7% in the United States to about 30% in continental Europe and 36% in the UK, reflecting which individual dogs were imported as foundation stock.
This means that breed-level prevalence averages are useful guidelines but should not replace individual testing. Your specific dog's risk depends on its actual genetics, not population statistics.
Why Prevalence Has Not Decreased Faster
With testing available since 2004 and widespread since around 2010, you might expect MDR1 prevalence to have dropped dramatically. It has not, and the reasons are instructive.
First, in breeds where 70% of the population carries the mutation, aggressive selection against carriers would devastate genetic diversity. Responsible breeders understand that eliminating carriers means eliminating the majority of the breeding population, which introduces far worse genetic problems through inbreeding depression. The correct approach, as discussed in our breeding decisions guide, is gradual frequency reduction through smart pairings, not wholesale elimination of carrier dogs.
Second, not all breeders test. Despite two decades of available testing, some breeders in affected breeds still do not screen for MDR1. Casual breeders, accidental litters, and puppy mills contribute untested dogs to the population, maintaining mutation frequency.
Breed frequency should drive how urgently you act. Collies, Australian Shepherds, Shetland Sheepdogs, and other herding lines carry the MDR1 mutation at rates high enough that testing is a first-week priority, not a someday task. Breeds with low carrier rates can wait, but waiting has no upside. A cheek swab or blood sample can be collected once the puppy is weaned and identified, and results are valid for life, so there is no reason to delay past the first veterinary visit. For a practical walkthrough of when to test a puppy, including sample timing and how to read the genotype report, that guide covers the decision point by point.
Third, the MDR1 mutation itself carries no fitness disadvantage in the absence of P-glycoprotein substrate drugs. In a natural environment without modern pharmaceuticals, M/M dogs are as healthy and reproductively successful as N/N dogs. There is no natural selection pressure against the mutation, so without human-directed testing and breeding management, the frequency remains stable.
Emerging Research on Breed-Specific P-glycoprotein Expression
Recent research has revealed that even among N/N dogs, P-glycoprotein expression levels can vary between breeds. Some breeds appear to have naturally lower P-glycoprotein activity than others, even without carrying the MDR1 deletion. This finding, still preliminary, suggests that drug sensitivity in dogs may be more nuanced than a simple mutation-present-or-absent model.
Several research groups are investigating whether breed-specific differences in ABCB1 gene regulation — not the deletion itself but how actively the gene is expressed — contribute to observed variations in drug metabolism. If confirmed, this could lead to breed-specific dosing guidelines that account for both MDR1 genotype and baseline P-glycoprotein expression levels. For an in-depth look at how researchers are exploring solutions at the genetic level, our gene therapy research overview covers the latest approaches.
Understanding MDR1 prevalence across breeds also matters for the broader picture of herding breed drug sensitivity. If you want to explore how the mutation interacts with specific drug reactions in clinical settings, the case studies compiled at Ivermectin Sensitivity provide real-world examples of how breed prevalence translates to clinical outcomes.
What This Means for You
If your dog belongs to any breed listed above, or has any herding breed ancestry, testing is not optional. It is a basic responsibility of ownership. The test is inexpensive, noninvasive, and provides information that could save your dog's life during a routine veterinary visit.
Do not rely on prevalence statistics to decide whether your individual dog needs testing. A breed with 5% prevalence still means one in twenty dogs carries the mutation. Would you accept a one-in-twenty chance that your dog could have a fatal reaction to a common medication without checking first?
Test your dog. Know the number. Share it with your veterinarian. That simple act remains the single most effective thing any owner can do to protect a herding breed dog from preventable drug toxicity.
Frequently Asked Questions About MDR1 Breed Prevalence
Are all herding breeds at risk for MDR1?
No. Despite the common assumption, prevalence varies dramatically across herding breeds. Collies and Australian Shepherds sit at the top of the risk pyramid, while Border Collies show only low carrier rates and the mutation has not been documented at all in some herding breeds, such as the Australian Cattle Dog. Herding breed ancestry raises suspicion, not certainty, which is why individual testing remains the only reliable answer for any dog with potential exposure.
Can a mixed breed without obvious herding traits still carry MDR1?
Yes, and this is increasingly common. Doodle crosses involving Australian Shepherds, Collies, or Shelties can carry the mutation despite curly coats and non-traditional appearances. Even one herding ancestor at the great-grandparent level (about 12.5% ancestry) is enough to pass MDR1 forward. If a DNA panel shows any herding contribution, request a specific MDR1 test rather than relying on visual breed cues.
Why do prevalence numbers differ between testing laboratories?
Each laboratory reports rates based on the dogs that voluntarily submit samples, and that population is not random. Owners who test tend to be more engaged breeders, which can skew rates downward in popular show lines. Sample sizes also differ widely. Numbers from Washington State University, which has offered the test since the mid-2000s, and from large commercial panels such as Embark are the most statistically robust because they pool very large numbers of results.
Has MDR1 prevalence dropped since testing became widely available?
Marginally, but less than expected. In high-prevalence breeds, aggressively removing carriers would collapse genetic diversity, so responsible breeders pair carriers with clear dogs rather than eliminating them. Many casual breeders never test at all. Without selection pressure from the mutation itself, frequencies stay nearly stable across generations, which is why breed-level estimates have changed little over time.